| 000 | 01844 a2200517 4500 | ||
|---|---|---|---|
| 005 | 20250515205051.0 | ||
| 264 | 0 | _c20100505 | |
| 008 | 201005s 0 0 eng d | ||
| 022 | _a1473-558X | ||
| 024 | 7 |
_a10.1097/WNR.0b013e32833774bf _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aFitzsimmons, Bethany L | |
| 245 | 0 | 0 |
_aRole of spinal p38alpha and beta MAPK in inflammatory hyperalgesia and spinal COX-2 expression. _h[electronic resource] |
| 260 |
_bNeuroreport _cMar 2010 |
||
| 300 |
_a313-7 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, N.I.H., Extramural | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 | _aBlotting, Western |
| 650 | 0 | 4 |
_aCarrageenan _xadministration & dosage |
| 650 | 0 | 4 |
_aCyclooxygenase 1 _xmetabolism |
| 650 | 0 | 4 |
_aCyclooxygenase 2 _xmetabolism |
| 650 | 0 | 4 | _aDisease Models, Animal |
| 650 | 0 | 4 |
_aDown-Regulation _xdrug effects |
| 650 | 0 | 4 |
_aHyperalgesia _xchemically induced |
| 650 | 0 | 4 | _aInflammation |
| 650 | 0 | 4 | _aInjections, Spinal |
| 650 | 0 | 4 |
_aMAP Kinase Signaling System _xdrug effects |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aMembrane Proteins _xmetabolism |
| 650 | 0 | 4 |
_aOligonucleotides, Antisense _xadministration & dosage |
| 650 | 0 | 4 |
_aPain _xchemically induced |
| 650 | 0 | 4 |
_aPain Measurement _xdrug effects |
| 650 | 0 | 4 |
_aProtein Isoforms _xmetabolism |
| 650 | 0 | 4 | _aRats |
| 650 | 0 | 4 | _aRats, Sprague-Dawley |
| 650 | 0 | 4 |
_aSpinal Cord _xdrug effects |
| 650 | 0 | 4 | _aTime Factors |
| 650 | 0 | 4 |
_ap38 Mitogen-Activated Protein Kinases _xmetabolism |
| 700 | 1 | _aZattoni, Michela | |
| 700 | 1 | _aSvensson, Camilla I | |
| 700 | 1 | _aSteinauer, Joanne | |
| 700 | 1 | _aHua, Xiao-Ying | |
| 700 | 1 | _aYaksh, Tony L | |
| 773 | 0 |
_tNeuroreport _gvol. 21 _gno. 4 _gp. 313-7 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1097/WNR.0b013e32833774bf _zAvailable from publisher's website |
| 999 |
_c19506025 _d19506025 |
||